Aranesp Trademark Details

Aranesp was registered on Tuesday, August 13, 2002 and is currently owned by Amgen Inc. under the registration number 2607924 . This mark is alive with a status of Registered and Renewed. The last case file activity for this mark occured 11 years ago on Wednesday, August 8, 2012, according to the United State Patent & Trademark Office
Word Mark Aranesp
Status Alive Registered 800 — Registered and Renewed

Current Owner

Amgen Inc. of Newbury Park, CA

View all trademarks for Amgen Inc.
Other Trademarks for Amgen Inc.
Serial Number 75849800
Registration Number 2607924
Status Date Wednesday, August 8, 2012
Filing Date Wednesday, August 8, 2012
Registration Date Tuesday, August 13, 2002
Attorney Mark I. Feldman, Christina L. Martini

Correspondent

MARK I. FELDMAN, CHRISTINA L. MARTINI
DLA Piper LLP (US)
P.O. BOX 64807
CHICAGO IL 60664-0807

Case File Statements

Goods & Services Prescription pharmaceuticals for use in stimulating red blood cell production; prescription pharmaceuticals, namely, erythropoiesis stimulating protein

Classifications

International Class Codes
005 — Class 5 includes mainly pharmaceuticals and other preparations for medical or veterinary purposes.
U.S. Class Codes 006, 018, 044, 046, 051, 052
Status 6 — Active
Status Date Wednesday, March 1, 2000
First Use Anywhere Monday, October 1, 2001
First Use In Commerce Monday, October 1, 2001
Primary Code 005

You must be signed in to print.

Once signed in, look for the PDF button.